We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 5,019

ETF Roundup - Issue 4
  • Morgan Lewis & Bockius LLP
  • USA
  • August 13 2018

The US Securities and Exchange Commission (SEC) voted unanimously on June 28 to propose Rule 6c-11 under the Investment Company Act of 1940 (1940 Act


The Cost of Data Breaches in 2018
  • Morgan Lewis & Bockius LLP
  • USA
  • August 10 2018

This July, the 2018 Cost of Data Breach Study: A Global Overview was released as an independent study by Ponemon Institute, LLC, sponsored by IBM


Global Immigration Updates: Australia, China, and Germany
  • Morgan Lewis & Bockius LLP
  • Australia, China, Germany
  • August 10 2018

Recent immigration updates include a new act requiring contributions to the Skilling Australians Fund in Australia; an announcement that residents


Shanghai Regulator: Speaking Fees to Physicians Constitute Bribery
  • Morgan Lewis & Bockius LLP
  • China
  • August 10 2018

A local regulator in Shanghai has recently fined a domestic medical device company for commercial bribery after determining that the company had


The World’s Sandbox: UK Financial Conduct Authority Announces Global Fintech Network
  • Morgan Lewis & Bockius LLP
  • United Kingdom
  • August 9 2018

The UK Financial Conduct Authority (FCA) issued a press release on August 7 announcing that it has joined 11 other financial regulators from around


SEC Amends Rule 701 to Increase Enhanced Disclosure Threshold to $10 Million
  • Morgan Lewis & Bockius LLP
  • USA
  • August 9 2018

In our June 21 post, we addressed the provisions of Section 507 of the Economic Growth, Regulatory Relief, and Consumer Protection Act (the Act


China National Drug Administration Sets Guidelines for Overseas Drug Trial Data
  • Morgan Lewis & Bockius LLP
  • China
  • August 9 2018

In an effort to increase the availability of pharmaceutical treatments in China, the China National Drug Administration has recently released


Expanding Multiemployer Health Plan Coverage to Non-Bargaining Unit Employees
  • Morgan Lewis & Bockius LLP
  • USA
  • August 7 2018

Employers that do not have large employee populations have for many years struggled to provide competitive health coverage to their employees. In an


Federal Circuit Weighs in on Prosecution History Estoppel Applied to Design Patents
  • Morgan Lewis & Bockius LLP
  • USA
  • August 6 2018

Applicants should consider how including multiple embodiments in a design patent application may later impact the scope of protection. In Advantek


Ninth Circuit: ERISA Section 502(a)(2) Claims Beyond Scope of Employees’ Arbitration Agreements
  • Morgan Lewis & Bockius LLP
  • USA
  • August 6 2018

On July 24, the US Court of Appeals for the Ninth Circuit held in Munro v. University of Southern California that ERISA Section 502(a)(2) claims for